상단으로
Contact Us

Together,
we can build
healthier communities!

Why do we still need PCR?

COVID-19, along with other respiratory infections such as influenza and the common cold, remains a serious threat to our health.
Now, we have a greater need for PCR testing as it can accurately distinguish respiratory viruses for appropriate treatment even for asymptomatic and pre-symptomatic cases.
Proactive and routine PCR testing is more important than ever to safeguard our healthy living and to prevent another pandemic.

Communities that can benefit the most

A community where social interaction and group-based activities are essential

A community with individuals who are more vulnerable to repiratory infections

Workplace

Factory

Kindergarten

School

University

Nursing Home

Seegene
In-Life PCR

Easy and convenient PCR tests for anyone, anytime, anywhere.

Seegene

(Including subsidiaries
& distributors)

Provide All-in-one solution

Partners

(C-labs, hospitals, etc.)

Perform tests & results

Communities

(Including asymptomatic individuals)

Join In-Life PCR campaign

Partner benefits for Seegene In-Life PCR

Full Supports for
Implementation

Seegene will provide everything you need
to adopt Seegene In-Life PCR, including instruments, software, and technical support.

Easy Operation
& Management

Operation is easy with a dedicated web/mobile application.

Syndromic
Expandability

Test menu can be expanded beyond respiratory to other infectious diseases using Seegene’s full product lineup.

Join Seegene In-Life PCR
to build healthier communities through routine PCR testing

Seegene STARlet-AIOS

One streamlined automated system
for all high multiplex real-time PCR assays

How Seegene In-Life PCR Works

*Materials supported may vary depending on partnership terms & conditions.

Related Products

Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

One tube, primary screening of SARS-CoV-2, Flu A, Flu B and RSV A/B

Allplex™ RV Master Assay

One tube test for 19 respiratory viruses
(including Flu A, Flu B, RSV, MPV, AdV, HRV, PIV and SARS-CoV-2)